Nuray Böğürcü

666 total citations
10 papers, 291 citations indexed

About

Nuray Böğürcü is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Nuray Böğürcü has authored 10 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Nuray Böğürcü's work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (2 papers) and ATP Synthase and ATPases Research (2 papers). Nuray Böğürcü is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (2 papers) and ATP Synthase and ATPases Research (2 papers). Nuray Böğürcü collaborates with scholars based in Germany, Türkiye and Belgium. Nuray Böğürcü's co-authors include Boyan K. Garvalov, Till Acker, Sascha Seidel, Kemal Korkmaz, Alina Filatova, Bilge Debeleç-Bütüner, Lokman Varışlı, Erdal Bedi̇r, Canan Sevimli-Gür and Fahri Saatcioglu and has published in prestigious journals such as Nature Communications, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Nuray Böğürcü

10 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuray Böğürcü Germany 8 219 91 74 53 31 10 291
Tahera Zabuawala United States 7 248 1.1× 80 0.9× 144 1.9× 137 2.6× 33 1.1× 7 426
Yael Morgenstern Israel 4 228 1.0× 60 0.7× 118 1.6× 87 1.6× 26 0.8× 9 364
Olivier Masson France 8 147 0.7× 114 1.3× 82 1.1× 29 0.5× 56 1.8× 9 326
Zaili Luo China 11 241 1.1× 95 1.0× 77 1.0× 31 0.6× 52 1.7× 15 367
Vidusha Devasthali United States 5 245 1.1× 85 0.9× 148 2.0× 29 0.5× 16 0.5× 5 371
Pei-Qi Huang China 12 195 0.9× 124 1.4× 120 1.6× 119 2.2× 30 1.0× 22 432
Laura Pietrovito Italy 9 206 0.9× 172 1.9× 94 1.3× 23 0.4× 30 1.0× 13 361
Shuzhou Chu China 13 288 1.3× 92 1.0× 92 1.2× 37 0.7× 45 1.5× 19 403
Daehee Hwang South Korea 8 251 1.1× 66 0.7× 75 1.0× 80 1.5× 40 1.3× 14 392
Shu Lin China 8 238 1.1× 102 1.1× 159 2.1× 26 0.5× 19 0.6× 16 372

Countries citing papers authored by Nuray Böğürcü

Since Specialization
Citations

This map shows the geographic impact of Nuray Böğürcü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuray Böğürcü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuray Böğürcü more than expected).

Fields of papers citing papers by Nuray Böğürcü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuray Böğürcü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuray Böğürcü. The network helps show where Nuray Böğürcü may publish in the future.

Co-authorship network of co-authors of Nuray Böğürcü

This figure shows the co-authorship network connecting the top 25 collaborators of Nuray Böğürcü. A scholar is included among the top collaborators of Nuray Böğürcü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuray Böğürcü. Nuray Böğürcü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Böğürcü, Nuray, et al.. (2023). Beyond ribosome biogenesis: noncoding nucleolar RNAs in physiology and tumor biology. Nucleus. 14(1). 2274655–2274655. 4 indexed citations
2.
Böğürcü, Nuray & Gabriele Bergers. (2022). R-2-HG assists IDH1-mutant solid tumors by promoting angiogenesis. Cell Research. 32(9). 795–796. 1 indexed citations
3.
Schagdarsurengin, Undraga, Chengsheng Luo, Heiko Slanina, et al.. (2021). Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature. Clinical Epigenetics. 13(1). 211–211. 7 indexed citations
4.
Böğürcü, Nuray, Sascha Seidel, Boyan K. Garvalov, & Till Acker. (2018). Analysis of Hypoxia and the Hypoxic Response in Tumor Xenografts. Methods in molecular biology. 1742. 283–300. 7 indexed citations
5.
Filatova, Alina, et al.. (2016). Acidosis Acts through HSP90 in a PHD/VHL-Independent Manner to Promote HIF Function and Stem Cell Maintenance in Glioma. Cancer Research. 76(19). 5845–5856. 72 indexed citations
6.
Böğürcü, Nuray, Ángel M. Cuesta, María R. Aburto, et al.. (2016). EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance. Nature Communications. 7(1). 12329–12329. 55 indexed citations
7.
Hahn, Andreas, Jessica Lauriol, Josef Thul, et al.. (2015). Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: Palliative treatment with a rapamycin analog. American Journal of Medical Genetics Part A. 167(4). 744–751. 55 indexed citations
9.
Böğürcü, Nuray, et al.. (2011). ALCAPs induce mitochondrial apoptosis and activate DNA damage response by generating ROS and inhibiting topoisomerase I enzyme activity in K562 leukemia cell line. Biochemical and Biophysical Research Communications. 409(4). 738–744. 29 indexed citations
10.
Varışlı, Lokman, et al.. (2011). Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells. Molecular and Cellular Endocrinology. 350(1). 107–117. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026